Oncolytics Biotech (TSE:ONC) Stock Passes Above 200 Day Moving Average – Here’s What Happened

Oncolytics Biotech Inc. (TSE:ONC)’s stock price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of C$14.90 and traded as high as C$14.90. Oncolytics Biotech shares last traded at C$14.90, with a volume of 280 shares trading hands.

Oncolytics Biotech Price Performance

The company has a current ratio of 2.88, a quick ratio of 8.86 and a debt-to-equity ratio of 14.58. The firm has a market cap of C$1.50 billion, a P/E ratio of -40.27 and a beta of 0.80. The company has a fifty day moving average price of C$14.90 and a two-hundred day moving average price of C$14.90.

Oncolytics Biotech Company Profile

Oncolytics Biotech Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma. It has a co-development agreement with Merck KGaA and Pfizer Inc to co-develop pelareorep, as well as with Roche Holding AG.